Schedule 13G ownership disclosure
Hinge Health Inc
Class A Common Stock, par value $0.00001 per share · CUSIP: 433313103
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Insight Venture Partners X, LP
Shares: 4,681,897 · Class: 9.9%
- Insight Venture Partners (Cayman) X, LP
Shares: 3,839,211 · Class: 8.1%
- Insight Venture Partners (Delaware) X, LP
Shares: 742,658 · Class: 1.6%
- Insight Venture Partners X (Co-Investors), LP
Shares: 111,398 · Class: 0.2%
- Insight Venture Associates X, L.P.
Shares: 9,375,164 · Class: 19.8%
- Insight Venture Associates X, Ltd.
Shares: 9,375,164 · Class: 19.8%
- Insight Holdings Group, LLC
Shares: 9,375,164 · Class: 19.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000899140-26-000195
- Form type
- SCHEDULE 13G/A
- Filer
- Hinge Health, Inc.
- CIK
- CIK 1673743
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership